Publicaciones (56) Publicaciones de JOSE MARIA ECHAVE SUSTAETA

2023

  1. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

    Respiratory Research, Vol. 24, Núm. 1

  2. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  3. Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment

    International journal of chronic obstructive pulmonary disease, Vol. 18, pp. 2887-2893

  4. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 12, pp. 1703-1715

  3. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

    Respiratory Medicine, Vol. 200

  4. Treatable traits in the NOVELTY study

    Respirology, Vol. 27, Núm. 11, pp. 929-940

  5. [Translated article] ANTES Program: One Year on

    Archivos de Bronconeumologia

2021

  1. Characterization of COPD admissions during the first COVID-19 outbreak

    International Journal of COPD, Vol. 16, pp. 1549-1554

  2. Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages

    Archivos de Bronconeumologia

2020

  1. Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

    Therapeutic Advances in Respiratory Disease, Vol. 14

2019

  1. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

    The Lancet Respiratory Medicine, Vol. 7, Núm. 9, pp. 771-779

2016

  1. Author’s reply

    International Journal of COPD

  2. The lung function profile of once-daily tiotropium and olodaterol via respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via a accuhaler® (Energito® study)

    International Journal of COPD, Vol. 11, pp. 193-205

2014

  1. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?

    International journal of chronic obstructive pulmonary disease, Vol. 9, pp. 1307-1314

  2. Non-Invasive Ventilation

    Clinical Intensive Care Medicine

2013

  1. Prevalencia de anemia asociada a la enfermedad pulmonar obstructiva crónica: Estudio de las variables asociadas

    Archivos de Bronconeumologia, Vol. 49, Núm. 9, pp. 383-387

  2. Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial

    Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649

2012

  1. Experiencia inicial en el diagnóstico de patologías distintas al carcinoma broncogénico por ecobroncoscopia

    Revista de Patologia Respiratoria, Vol. 15, Núm. 4, pp. 136-139